|
This report is being submitted as part of remediation activities associated with capa # 643143, which is addressing mdr reporting guidance from fdas 1995 preamble, which ensures complaints related to corrections and recalls which were previously reported to fda under 21 cfr 806 are now reported as mdrs; this is not a new malfunction/event.Product event summary: the monitor (b)(6) and one monitor ac adapter (b)(6) were returned for evaluation.One controller (b)(6) was not returned.There were no allegations against the monitor ac adapter or the controller.Various analyses were conducted and reviewed in order to evaluate the performance of the devices in relation to the reported event.Failure analysis of the returned monitor ac adapter revealed that the device passed visual inspection and functional testing.Internal inspection did not reveal any anomalies.Failure analysis of the returned monitor revealed that the device passed visual inspection.Functional testing revealed that the logs obtained from the monitor were unable to be used to create an autologs report.This observation was likely perceived as the reported data transfer error.Internal inspection did not reveal any anomalies.It was determined that the monitor contained an updated software version which embeds a text string in the downloaded log files, which prevents the autologs system from creating an autologs report.This observation did not interfere with the functionality of the monitor or the information recorded within the log files.No other findings were observed during log file analysis.As a result, the reported event was confirmed.Based on the investigation conducted, the most likely root cause of the reported event can be attributed to a monitor software version that is incompatible with autologs.Capa pr00617627 is investigating this issue.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|